Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination product containing **standardized extracts of Passiflora incarnata (passion flower)** and **isoflavones (plant-derived phytoestrogens, often extracted from soy)**. This combination has been developed for the treatment of **climacteric (menopausal) symptoms** in women who prefer non-hormonal, plant-based therapies. - **Passiflora incarnata** contains active flavonoids such as vitexin and a benzoflavone moiety, conferring anxiolytic, sedative, and possible hormone-modulating effects by influencing serotonin and GABAergic neurotransmission, and by decreasing monoamine oxidase activity[2][3][4]. - **Isoflavones** act as phytoestrogens, providing mild estrogenic activity, which may reduce vasomotor symptoms and support bone and cardiovascular health in postmenopausal women[1]. The combination is aimed at providing **relief of menopausal symptoms** such as hot flashes, insomnia, mood swings, and anxiety, in postmenopausal women, especially those seeking alternatives to hormone replacement therapy[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on passiflora incarnata + isoflavone.